Weight loss doctor in Colorado Springs
Are you ready to be a healthy YOU?
Losing weight can be hard, but you don’t have to do it alone. Dr. Blixt specializes in Bariatric medicine, and the treatment of obesity related disorders. His approach to physician assisted weight loss programs is different, built custom to each individual client, and addresses all factors that could be impacting your success.
With Dr. Blixt’s weight loss program, we can help you find the reason why losing weight may be difficult, and address your medical issues individually. By assessing for medical or genetic markers that predispose you to weight issues, Dr. Blixt helps his patients build a plan that best fits their medical history. Obesity is a complex hormonal disease. We will evaluate you and treat you medically, but also work to de-stress your life, relieve anxiety, and discuss any behavioral aspects that may be impacting your weight loss journey.
Whether you need medication assisted treatment, medication management, or a custom physician assisted weight loss program, Dr. Blixt can help! Contact him today to set your first appointment.
Did you know?
The way you were brought up around food, your cultural beliefs about food, and your family history all have an impact on how you’ll lose weight? Dr. Blixt can help you deconstruct the cultural challenges with losing weight. We’ll look for underlying causes that could be preventing you from losing weight.
We Evaluate how these impact your ability to lose weight:
- Sleep habits
- Genetic Conditions
- Co-Morbid Diseases
- Pre-Existing Conditions
- Cultural Impacts
- Thyroid Function
Weight Loss Program Requirement Information:
To participate in our program, patients may meet the following criteria.
- Body mass index* (BMI) greater than or equal to 30 kg/m²; or
- BMI greater than or equal to 27 kg/m² with any of the following obesity-related risk factors considered serious enough to warrant pharmacotherapy: (We will verify this info when you call for an appointment).
- Coronary heart disease
- HDL cholesterol less than 35 mg/dL, or
- LDL cholesterol greater than or equal to 160 mg/dL, or
- Triglycerides greater than or equal to 400 mg/dL
- Obstructive sleep apnea
- Type 2 Diabetes Mellitus
- Osteoarthritis aggravated by weight
Medical evaluation for overweight or obese individuals will include a comprehensive history and physical exam, review and ordering of pertinent studies which may include:
- Comprehensive History & Physical Examination
- Complete Blood Count
- Electrocardiogram (EKG)
- Glucose Tolerance Test
- Lipid Profile
- Metabolic & Chemistry Profile
- Thyroid Function Tests
Wegovy Weight Loss Medication – Semaglutide (Generic)
GLP-1 Agonist FDA Approved Weight Loss
The weight-loss drug Wegovy, the same drug as Semaglutide (generic), is described as a ‘game-changer’ for obesity. Semaglutide, the generic medication for Wegovy and other GLP – 1 agonist medications, are currently used for many years as treatment for Type 2 Diabetes.
Soon after these medications were introduced for Diabetes results showed dramatic weight loss for many. In fact when these medications were studied in non diabetic patients the weight loss results were just as dramatic maybe more so. However, whether someone has Type 2 Diabetes Mellitus or not the results from this family of medications is dramatic for helping people shed their weight.
People report losing significant weight, increased feelings of fullness, reduced cravings for tempting food which may extend to reduced cravings for alcohol as well! Semaglutide(Wegovy) and other similar medications such as Saxenda, Ozempic and other GLP-1 agonists are indeed “game changers.”
In fact a new medication in this family was released in 2022 called Mounjaro. While it is not yet FDA approved for weight loss, only Type 2 diabetes, the FDA has fast tracked this medication for rapid approval to be used for obesity. So something to look out for in 2023.
Early studies indicate it maybe more effective for weight loss than other medications in this family. However as a whole the medications in this family called GLP-1 agonists are changing how we all look at weight and obesity including medical providers themselves. My hope is this will continue to decrease stigma with people who struggle with these conditions and all the other medical conditions that can be associate with being overweight or obese. This is the opinion as well of many medical professions who specialize in Obesity and its related conditions.